CLINICAL IMPACT OF CREATING A PREDETERMINED ATRIAL COMMUNICATION IN THE MANAGEMENT OF SEVERE PULMONARY HYPERTENSION USING THE ATRIAL FLOW REGULATOR DEVICE

MLA

Joseph J. Vettukattil, et al. “Clinical Impact of Creating a Predetermined Atrial Communication in the Management of Severe Pulmonary Hypertension Using the Atrial Flow Regulator Device.” Journal of the American College of Cardiology, vol. 71, Mar. 2018, p. A1948. EBSCOhost, https://doi.org/10.1016/s0735-1097(18)32489-6.

APA

Joseph J. Vettukattil, Ramasamy Rajeshkumar, Ata Firouzi, Bennett P. Samuel, Vishal R. Kaley, Kothandam Sivakumar, Sven Dittrich, Nagib Dahdah, Dietmar Schranz, & Daniel Springmuller. (2018). Clinical Impact of Creating a Predetermined Atrial Communication in the Management of Severe Pulmonary Hypertension Using the Atrial Flow Regulator Device. Journal of the American College of Cardiology, 71, A1948. https://doi.org/10.1016/s0735-1097(18)32489-6

Chicago

Joseph J. Vettukattil, Ramasamy Rajeshkumar, Ata Firouzi, Bennett P. Samuel, Vishal R. Kaley, Kothandam Sivakumar, Sven Dittrich, Nagib Dahdah, Dietmar Schranz, and Daniel Springmuller. 2018. “Clinical Impact of Creating a Predetermined Atrial Communication in the Management of Severe Pulmonary Hypertension Using the Atrial Flow Regulator Device.” Journal of the American College of Cardiology 71 (March): A1948. doi:10.1016/s0735-1097(18)32489-6.